Deutsche Bank Ag\ Ascendis Pharma A/S Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Deutsche Bank Ag\ holds 45,506 shares of ASND stock, worth $6.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,506

Previous 181,029 74.86%

Holding current value

$6.21 Million

Previous $24.7 Million 72.48%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$113.0 - $153.43 $15.3 Million - $20.8 Million	-135,523 Reduced 74.86%	45,506 $6.8 Million
Q2 2024 Aug 14, 2024	SELL	$121.07 - $153.67 $9.69 Million - $12.3 Million	-80,000 Reduced 30.65%	181,029 $24.7 Million
Q1 2024 May 15, 2024	SELL	$123.45 - $159.4 $13.8 Million - $17.8 Million	-111,385 Reduced 29.91%	261,029 $39.5 Million
Q4 2023 Feb 14, 2024	BUY	$86.1 - $127.36 $980,248 - $1.45 Million	11,385 Added 3.15%	372,414 $46.9 Million
Q2 2023 Aug 14, 2023	SELL	$69.96 - $97.84 $311,951 - $436,268	-4,459 Reduced 1.22%	361,029 $32.2 Million
Q1 2023 May 15, 2023	SELL	$104.9 - $126.78 $68,185 - $82,407	-650 Reduced 0.18%	365,488 $39.2 Million
Q1 2022 May 13, 2022	SELL	$102.18 - $135.75 $571,288 - $758,978	-5,591 Reduced 1.5%	366,138 $43 Million
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $679,476 - $907,002	-5,346 Reduced 1.42%	371,729 $50 Million
Q3 2021 Nov 04, 2021	BUY	$112.67 - $176.92 $14.7 Million - $23 Million	130,216 Added 52.75%	377,075 $60.1 Million
Q2 2021 Aug 11, 2021	BUY	$121.62 - $145.29 $437,588 - $522,753	3,598 Added 1.48%	246,859 $32.5 Million
Q1 2021 May 13, 2021	SELL	$124.92 - $173.33 $2.29 Million - $3.17 Million	-18,317 Reduced 7.0%	243,261 $31.4 Million
Q4 2020 Feb 16, 2021	SELL	$151.2 - $182.76 $28,425 - $34,358	-188 Reduced 0.07%	261,578 $43.6 Million
Q3 2020 Nov 12, 2020	BUY	$134.29 - $154.32 $2.01 Million - $2.31 Million	14,986 Added 6.07%	261,766 $40.4 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $1.3 Million - $1.82 Million	-11,687 Reduced 4.52%	246,780 $36.5 Million
Q1 2020 May 14, 2020	SELL	$97.01 - $145.11 $1.51 Million - $2.25 Million	-15,533 Reduced 5.67%	258,467 $29.1 Million
Q4 2019 Feb 14, 2020	BUY	$91.45 - $139.12 $1.67 Million - $2.54 Million	18,241 Added 7.13%	274,000 $38.1 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $12.4 Million - $15.4 Million	-129,285 Reduced 33.58%	255,759 $24.6 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $11.4 Million - $14 Million	106,214 Added 38.09%	385,044 $44.3 Million
Q1 2019 May 15, 2019	BUY	$62.15 - $129.99 $9.85 Million - $20.6 Million	158,543 Added 131.8%	278,830 $32.8 Million
Q4 2018 Feb 14, 2019	BUY	$55.16 - $69.67 $1.11 Million - $1.4 Million	20,105 Added 20.07%	120,287 $7.54 Million
Q3 2018 Dec 21, 2021	BUY	$63.77 - $76.28 $362,022 - $433,041	5,677 Added 6.01%	100,182 $7.1 Million
Q3 2018 Nov 14, 2018	SELL	$63.77 - $76.28 $738,329 - $883,169	-11,578 Reduced 10.91%	94,505 $6.7 Million
Q2 2018 Apr 21, 2020	BUY	$58.55 - $73.92 $284,845 - $359,620	4,865 Added 4.81%	106,083 $7.06 Million
Q2 2018 Aug 14, 2018	SELL	$58.55 - $73.92 $52,636 - $66,454	-899 Reduced 0.88%	101,218 $6.73 Million
Q1 2018 Oct 18, 2019	BUY	$38.98 - $68.04 $154,282 - $269,302	3,958 Added 4.03%	102,117 $6.68 Million
Q1 2018 May 15, 2018	BUY	$38.98 - $68.04 $899,112 - $1.57 Million	23,066 Added 30.72%	98,159 $6.42 Million
Q4 2017 Feb 14, 2018	SELL	$31.98 - $40.38 $562,432 - $710,163	-17,587 Reduced 18.98%	75,093 $3.01 Million
Q3 2017 Nov 14, 2017	BUY	$26.89 - $37.1 $2.49 Million - $3.44 Million	92,680	92,680 $3.36 Million

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account